Ganoderma lucidum polysaccharide
Based on 1 publication(s) in Google Scholar
Ganoderma Lucidum/Reishi Extract is a Ganoderma lucidum extract. Ganoderma Lucidum/Reishi Extract reduces the expression of c-Myc, BCL-2, BCL-XL, TERT, PDGFB, eIF4G, Survivin, β-catenin, and eIF4E. Ganoderma Lucidum/Reishi Extract downregulates the gene expression of MMP-9. Ganoderma Lucidum/Reishi Extract upregulates the expression of IL8. Ganoderma Lucidum/Reishi Extract is applicable to the research of inflammatory breast cancer. Ganoderma Lucidum is used in the research of various diseases, such as allergy, arthritis, hypertension, neurasthenia, inflammation, and cancer.
For research use only. We do not sell to patients.
- Purity: 41.20%
-
Storage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Ganoderma lucidum polysaccharide
More
Biological Activity
|
MMP-9 |
IL-8 |
eIF4G |
eIF4E |
Bcl-xL |
Bcl-2 |
Ganoderma Lucidum/Reishi Extract (0.05-1.0 mg/mL; 24-96 h) selectively inhibits viability across multiple cancer cell lines, including SUM-149 IBC cells (with 50% inhibition at 0.25 mg/mL over 96 hours), while causing minimal viability reduction in noncancerous MCF10A mammary epithelial cells[1].
Ganoderma Lucidum/Reishi Extract (0.5 mg/mL; 24 h) induces apoptosis in ~90% of SUM-149 IBC cells after 24-hour treatment with 0.5 mg/mL[1].
Ganoderma Lucidum/Reishi Extract (0.5 mg/mL; 24 h) inhibits invasion of SUM-149 IBC cells by 80% after 24-hour treatment with 0.5 mg/mL[1].
Ganoderma Lucidum/Reishi Extract (0.5 mg/mL; 48 h) disrupts tumor spheroid formation in SUM-149 IBC cells after 48-hour treatment with 0.5 mg/mL[1].
Ganoderma Lucidum/Reishi Extract (0.5 mg/mL; 24 h) reduces MMP-2 and MMP-9 gelatinase activity by ~50% in SUM-149 IBC cells after 24-hour treatment with 0.5 mg/mL[1].
Ganoderma Lucidum/Reishi Extract (0.5 mg/mL; 24 h) reduces expression of key survival, adhesion, and translation-related proteins (including BCL-2, E-cadherin, eIF4G, c-Myc) in SUM-149 IBC cells after 24-hour treatment with 0.5 mg/mL[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SUM-149 inflammatory breast cancer (IBC) cells, MCF10A noncancerous mammary epithelial cells, MDA-MB-468 breast cancer cells, MDA-MB-435 breast cancer cells, A-172 glioma cells, MiaPaCa pancreatic cancer cells
-
Concentration:0.5-1.0 mg/mL (24 h incubation for all cell lines); 0.05-1.0 mg/mL (96 h incubation with dosing every 48 h for SUM-149 cells)
-
Incubation Time:24 h (all cell lines); 96 h (SUM-149 cells with dosing every 48 h)
-
Result:Reduced SUM-149 viability by 67% at 0.5 mg/mL and 98% at 1.0 mg/mL after 24 h.
Left MCF10A viability unchanged at 0.5 mg/mL and reduced it by 11% at 1.0 mg/mL after 24 h.
Reduced MDA-MB-468 viability by 31% at 0.5 mg/mL and an additional 45% at 1.0 mg/mL after 24 h.
Reduced MDA-MB-435 viability by 60% at 0.5 mg/mL and an additional 91% at 1.0 mg/mL after 24 h.
Reduced A-172 viability by 31% at 0.5 mg/mL and an additional 49% at 1.0 mg/mL after 24 h.
Reduced MiaPaCa viability by 41% at 0.5 mg/mL with no additional effect at 1.0 mg/mL after 24 h.
Increased SUM-149 viability by 14% at 0.05 mg/mL, reduced viability by 50% at 0.25 mg/mL, 82% at 0.5 mg/mL, and 90% at 1.0 mg/mL after 96 h.
Achieved 50% inhibition of SUM-149 viability at 0.25 mg/mL over 96 h.
-
Cell Line:SUM-149 IBC cells
-
Concentration:0.5 mg/mL
-
Incubation Time:24 h
-
Result:Impaired SUM-149 cell invasion into the Matrigel matrix by 80% compared to controls.
-
Cell Line:SUM-149 IBC cells
-
Concentration:0.5 mg/mL
-
Incubation Time:8 h
-
Result:Downregulated BCL2, CDKN2A, FGFR2, PDGFB, TERT, and MMP9.
Upregulated IL8.
-
Cell Line:SUM-149 IBC cells
-
Concentration:0.5 mg/mL
-
Incubation Time:24 h
-
Result:Reduced protein expression of BCL-2 (1.6-fold), BCL-XL (1.9-fold), survivin (1.3-fold), E-cadherin (1.7-fold), beta-catenin (1.3-fold), c-Myc (2-fold), p120-catenin (3-fold), eIF4G (2.2-fold), and eIF4E (1.3-fold) compared to controls.
Chemical Information
-
Appearance Solid
-
Color Brown to orange
-
SMILES
[Ganoderma lucidum polysaccharide]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications (1)
-
Journal Impact Factor
-
Most Recent
Solvent & Solubility
H2O : 4 mg/mL (ultrasonic and warming and heat to 60°C)
Purity & Documentation
-
Data Sheet (274 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Martínez-Montemayor MM, et al. Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer. Nutr Cancer. 2011;63(7):1085-1094. [Content Brief]
[2]. Sliva D, et al. Cellular and physiological effects of Ganoderma lucidum (Reishi). Mini Rev Med Chem. 2004;4(8):873-879. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Ganoderma lucidum polysaccharide Related Classifications
HY-159059 Related Classifications
Powered by Bioz
- Ganoderma lucidum polysaccharide
- c-Myc
- Bcl-2 Family
- Eukaryotic Initiation Factor (eIF)
- Survivin
- β-catenin
- MMP
- Interleukin Related
- MCF-7 cells
- Vero cells
- inflammatory breast cancer
- MCF10A mammary epithelial cells
- HL-60 leukemia cells
- U937 leukemia cells
- MT-4 cells
- HeLa cells
- SUM-149 IBC cells
- PC12 neuronal cells
- Inhibitor
- inhibitor
- inhibit